Komori
Medipal Holdings (7459) · RiskRestated

Change in distribution channel for direct sales of pet food by the manufacturer

First written in FY2025. 2 of 3 entries say "Restated". Latest entry: FY2026.

3entries
2years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2025 – FY20262025: 220252026: 12026
Same theme, other companies
Contraction of wholesale distribution flows as manufacturers shift to direct salesA theme 1 companies write about · 1 as a headwind · 0 as a tailwind

No other company in this theme has enough history to compare yet.

Full recordFilings, disclosures and news, newest first
  1. FY2026RestatedAnnual report

    「Although the wholesale business for veterinary pharmaceuticals and other products in the companion-animal field was affected by a change in distribution channels under which some products were sold directly by manufacturers, it remained firm due to the proactive introduction of new products and other measures.」

    Although the change in distribution channels for some products to direct sales by manufacturers continued to have an impact, the wholesale business for veterinary pharmaceuticals and other products remained firm due to the introduction of new products and other measures.
  2. FY2026-H1RestatedAnnual report

    「Although the wholesale business for veterinary pharmaceuticals and other products in the companion-animal field was affected by a change in distribution channels under which some products were sold directly by manufacturers, revenue increased due to an expansion in the number of trading manufacturers and the proactive introduction of new products.」

    Although the change in distribution channels for some products to direct sales by manufacturers continued to affect sales, revenue increased in the wholesale business for veterinary pharmaceuticals and other products due to an expansion in the number of trading manufacturers and the introduction of new products.
  3. FY2025First statedAnnual report

    「The operating environment for the wholesale business for veterinary pharmaceuticals and other products has remained challenging, as customers’ willingness to purchase has declined amid persistently high prices for production inputs, including feed and energy, due to the weaker yen. ”Although the wholesale business for veterinary pharmaceuticals and other products in the companion-animal field was affected by a change in distribution channels under which some pet food products were sold directly by manufacturers,”」

    The shift in distribution channels, with some pet food products moving to direct sales by manufacturers, can be identified for the first time as a standalone risk theme affecting the operating environment and sales of the wholesale business for veterinary pharmaceuticals and other products.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
Medipal Holdings's next results are scheduled for 2026-11-05. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.